Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
// Morad-Rémy Muhsin-Sharafaldine 1 , Sarah C. Saunderson 1 , Amy C. Dunn 1 , James M. Faed 2 , Torsten Kleffmann 3 , Alexander D. McLellan 1, 4 1 Department of Microbiology and Immunology, University of Otago, Dunedin, Otago, New Zealand 2 Department of Pathology, University of Otago, Dunedin, Otago, New Zealand 3 Centre for Protein Research, University of Otago, Dunedin, Otago, New Zealand 4 Department of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, Dunedin, Otago, New Zealand Correspondence to: Alexander D. McLellan, email: alex.mclellan@otago.ac.nz Keywords: tumor vesicles, apoptotic vesicles, coagulation, tissue factor, cancer immunity Received: April 06, 2016 Accepted: June 17, 2016 Published: July 22, 2016 ABSTRACT Extracellular vesicles (EV) are lipid particles released from eukaryotic cells into the extracellular fluid. Depending on the cell type or mechanism of release, vesicles vary in form and function and exert distinct functions in coagulation and immunity. Tumor cells may constitutively shed vesicles known as exosomes or microvesicles (MV). Alternatively, apoptosis induces the release of apoptotic blebs or vesicles (ApoV) from the plasma membrane. EV have been implicated in thrombotic events (the second highest cause of death in cancer patients) and tumor vesicles contribute to the anti-cancer immune response. In this study, we utilized the well characterized B16 melanoma model to determine the molecular composition and procoagulant and immunogenic potential of exosomes, MV and ApoV. Distinct patterns of surface and cytoplasmic molecules (tetraspanins, integrins, heat shock proteins and histones) were expressed between the vesicle types. Moreover, in vitro coagulation assays revealed that membrane-derived vesicles, namely MV and ApoV, were more procoagulant than exosomes–with tissue factor and phosphatidylserine critical for procoagulant activity. Mice immunized with antigen-pulsed ApoV and challenged with B16 tumors were protected out to 60 days, while lower protection rates were afforded by MV and exosomes. Together the results demonstrate distinct phenotypic and functional differences between vesicle types, with important procoagulant and immunogenic functions emerging for membrane-derived MV and ApoV versus endosome-derived exosomes. This study highlights the potential of EV to contribute to the prothrombotic state, as well as to anti-cancer immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · cited 1×
“For example, EV have been proposed to induce a pre-metastatic niche for cancer metastasis [4, 20, 22, 43] and contribute to thrombotic events, such as pulmonary”
BackgroundMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426 · cited 2×
“Remarkably, this finding is similar to an earlier comparison of apoptotic vesicles and exosomes released from mouse dendritic cells, and is also consistent with the exosome proteome of human dendritic cells [5, 12] or murine and human melanoma-derived exosomes [43, 48].”
BackgroundResultSemi-supervised learning for peptide identification from shotgun proteomics datasets
Käll, L., Canterbury, J. D., Weston, J., Noble, W. S., & MacCoss, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1113 · Cited by 2,424 · cited 1×
“The Percolator algorithm [68] was used to adjust the score threshold to an estimated peptide false discovery rate of 1%.”
MethodAbsolute Quantification of Proteins by LCMSE
Silva, J. C., Gorenstein, M. V., Li, G.-Z., Vissers, J. P. C., & Geromanos, S. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500230-mcp200 · Cited by 1,529
Akers, J. C., Gonda, D., Kim, R., Carter, B. S., & Chen, C. C. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1084-8 · Cited by 1,423
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
Clathrin: a unique protein associated with intracellular transfer of membrane by coated vesicles.
Pearse, B. M. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1255 · Cited by 683 · cited 1×
“As expected from previous reports [25, 26, 40], there was a preferential association of CD147 and clathrin with vesicles, as compared to the B16 parental cell line (Figure 2C, Table 1 and Supplementary Table 1).”
Result
Research works printed but not linked: 60
- Buzas, 2011, Membrane vesicles current state-of-the-art: emerging role of extracellular vesicles, Cell Mol Life Sci, 68, 2667, 10.1007/s00018-011-0689-3 · DOI · Paper page
- Segura, 2009, Membrane vesicles as conveyors of immune responses, Nat Rev Immunol, 9, 581, 10.1038/nri2567 · DOI · Paper page
- Bonnerot, 2005, Exosomal-like vesicles are present in human blood plasma, Int Immunol, 17, 879, 10.1093/intimm/dxh267 · DOI · Paper page
- McLellan, 2006, Circulating soluble forms of major histocompatibility complex antigens are not exosome-associated, Eur J Immunol, 36, 2875, 10.1002/eji.200636041 · DOI
- Sverdlov, 2012, Amedeo Avogadro's cry: what is 1 microg of exosomes?, Bioessays, 34, 873, 10.1002/bies.201200045 · DOI · Paper page
- Osanto, 2013, Cryo-electron microscopy of extracellular vesicles in fresh plasma, J Extracell Vesicles, 2
- Mackman, 2013, Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients, Blood, 122, 1873, 10.1182/blood-2013-04-460139 · DOI · Paper page
- Amigorena, 2001, Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles, J Immunol, 166, 7309, 10.4049/jimmunol.166.12.7309 · DOI · Paper page
- Schett, 2012, Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles, J Biol Chem, 287, 496, 10.1074/jbc.M111.273144 · DOI
- McLellan, 2016, The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles, Immunol Cell Biol, 94, 430, 10.1038/icb.2015.111 · DOI
- Rosen, 1994, Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes, J Exp Med, 179, 1317, 10.1084/jem.179.4.1317 · DOI · Paper page
- Grinstein, 2010, The distribution and function of phosphatidylserine in cellular membranes, Annual review of biophysics, 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
- Hallett, 2004, Adhesion and signaling by B cell-derived exosomes: the role of integrins, Faseb J, 18, 977, 10.1096/fj.03-1094fje · DOI · Paper page
- McLellan, 2008, Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor, J Immunol, 180, 8146, 10.4049/jimmunol.180.12.8146 · DOI · Paper page
- Rak, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nature cell biology, 10, 619, 10.1038/ncb1725 · DOI · Paper page
- Francis, 2008, Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation, J Thromb Haemost, 6, 1517, 10.1111/j.1538-7836.2008.02987.x · DOI · Paper page
- Wickline, 2011, Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis, Cancer Res, 71, 3792, 10.1158/0008-5472.CAN-10-4455 · DOI · Paper page
- Madden, 2011, Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor phosphatidylserine and phosphatidylethanolamine, Blood coagulation & fibrinolysis, 22, 680, 10.1097/MBC.0b013e32834ad7bc · doi:10.1097/mbc.0b013e32834ad7bc
- Olson, 2012, How apoptotic cells aid in the removal of their own cold dead bodies, Cell Death Differ, 19, 735, 10.1038/cdd.2012.25 · DOI · Paper page
- Basbaum, 2004, The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions, Oncogene, 23, 956, 10.1038/sj.onc.1207070 · DOI · Paper page
- Jelinek, 2014, Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation, Oncotarget, 5, 5686, 10.18632/oncotarget.3667 · DOI
- Clayton, 2010, Proteomics analysis of bladder cancer exosomes, Mol Cell Proteomics, 9, 1324, 10.1074/mcp.M000063-MCP201 · DOI · Paper page
- Adema, 2011, Antigen localization controls T cell-mediated tumor immunity, J Immunol, 187, 1281, 10.4049/jimmunol.1003905 · DOI
- Arancia, 2002, Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles, The Journal of experimental medicine, 195, 1303, 10.1084/jem.20011624 · DOI · Paper page
- Amigorena, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nature medicine, 4, 594, 10.1038/nm0598-594 · DOI · Paper page
- Rak, 2010, Microparticles in cancer, Seminars in thrombosis and hemostasis, 36, 888, 10.1055/s-0030-1267043 · DOI · Paper page
- Wickline, 2011, Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis, Cancer research, 71, 3792, 10.1158/0008-5472.CAN-10-4455 · DOI · Paper page
- Osanto, 2007, Microparticle-associated tissue factor activity: a link between cancer and thrombosis?, Journal of thrombosis and haemostasis, 5, 520, 10.1111/j.1538-7836.2007.02369.x · DOI · Paper page
- Pawlinski, 2012, Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer, Blood, 119, 5543, 10.1182/blood-2012-01-402156 · DOI · Paper page
- Francis, 2008, Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation, Journal of thrombosis and haemostasis, 6, 1517, 10.1111/j.1538-7836.2008.02987.x · DOI · Paper page
- Lyman, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, Journal of Thrombosis and Haemostasis, 5, 632, 10.1111/j.1538-7836.2007.02374.x · DOI · Paper page
- Taubman, 2008, Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer, Journal of Thrombosis and Haemostasis, 6, 1983, 10.1111/j.1538-7836.2008.03156.x · DOI · Paper page
- Weltermann, 2008, Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?, Seminars in thrombosis and hemostasis, 34, 199, 10.1055/s-2008-1079261 · doi:10.1055/s-2008-1079261
- McLellan, 2014, CD169 mediates the capture of exosomes in spleen and lymph node, Blood, 123, 208, 10.1182/blood-2013-03-489732 · DOI · Paper page
- McLellan, 2014, NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge, J Immunol, 192, 2514, 10.4049/jimmunol.1202797 · DOI
- McLellan, 2010, A defined serum-free medium useful for monitoring anti-melanoma responses induced by dendritic cell immunotherapy, J Immunol Methods, 352, 178, 10.1016/j.jim.2009.11.001 · doi:10.1016/j.jim.2009.11.001
- Barcinski, 2009, Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner, Cancer Lett, 283, 168, 10.1016/j.canlet.2009.03.041 · DOI · Paper page
- Reisfeld, 2010, Mouse models for melanoma: a personal perspective, Exp Dermatol, 19, 157, 10.1111/j.1600-0625.2009.00986.x · DOI
- Vader, 2016, Cells release subpopulations of exosomes with distinct molecular and biological properties, Sci Rep, 6, 22519, 10.1038/srep22519 · DOI · Paper page
- Olson, 2013, Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs, Cell Death Differ, 20, 1293, 10.1038/cdd.2013.69 · DOI · Paper page
- Nieto, 2015, Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines, Pigment Cell Melanoma Res, 28, 464, 10.1111/pcmr.12380 · DOI
- Zhang, 2013, Histone chaperones in nucleosome assembly and human disease, Nat Struct Mol Biol, 20, 14, 10.1038/nsmb.2461 · DOI · Paper page
- Duelli, 2012, MicroRNAs are exported from malignant cells in customized particles, Nucleic Acids Res, 40, 9125, 10.1093/nar/gks656 · DOI · Paper page
- Wied, 2012, Release of exosomes and microvesicles harbouring specific RNAs and glycosylphosphatidylinositol-anchored proteins from rat and human adipocytes is controlled by histone methylation, American Journal of Molecular Biology, 2, 187, 10.4236/ajmb.2012.23020 · DOI
- Mann, 1996, Blood clotting in minimally altered whole blood, Blood, 88, 3432, 10.1182/blood.V88.9.3432.bloodjournal8893432 · DOI · Paper page
- Esmon, 2011, Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4, Blood, 118, 1952, 10.1182/blood-2011-03-343061 · DOI · Paper page
- Abgrall, 2008, Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma, Thromb Haemost, 99, 767, 10.1160/TH07-09-0581 · DOI
- Neeves, 2014, Thrombin generation and fibrin formation under flow on biomimetic tissue factor-rich surfaces, J Thromb Haemost, 12, 373, 10.1111/jth.12491 · doi:10.1111/jth.12491
- Diamond, 2008, Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow, Blood, 111, 3507, 10.1182/blood-2007-08-106229 · DOI
- Monteiro, 2009, Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines, Melanoma Res, 19, 301, 10.1097/CMR.0b013e32832e40fe · doi:10.1097/cmr.0b013e32832e40fe
- van der Meijden, 2014, Differential roles of tissue factor and phosphatidylserine in activation of coagulation, Thromb Res, 133, S54, 10.1016/j.thromres.2014.03.022 · DOI
- Lorenz, 2013, During apoptosis HMGB1 is translocated into apoptotic cell-derived membranous vesicles, Autoimmunity, 46, 342, 10.3109/08916934.2012.750302 · DOI
- Zitvogel, 2008, Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies, Cancer Res, 68, 4026, 10.1158/0008-5472.CAN-08-0427 · DOI · Paper page
- Janoff, 1990, Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases, Proc Natl Acad Sci U S A, 87, 4112, 10.1073/pnas.87.11.4112 · DOI
- Amigorena, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat Med, 4, 594, 10.1038/nm0598-594 · DOI · Paper page
- Gabrielsson, 2013, Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity, J Immunol, 190, 2712, 10.4049/jimmunol.1203082 · DOI · Paper page
- Lord, 2001, Tumours can act as adjuvants for humoral immunity, Immunology, 102, 486, 10.1046/j.1365-2567.2001.01213.x · DOI
- Ham, 2009, Spin filter-based sample preparation for shotgun proteomics, Nat Methods, 6, 785
- Mechtler, 2014, MS Amanda a universal identification algorithm optimized for high accuracy tandem mass spectra, J Proteome Res, 13, 3679, 10.1021/pr500202e · DOI · Paper page
- McLellan, 2011, Effects of early atipamezole reversal of medetomidine-ketamine anesthesia in mice, J Am Assoc Lab Anim Sci, 50, 916
Cited by
Exosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,285
Willms, E., Cabañas, C., Mäger, I., Wood, M. J. A., & Vader, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00738 · Cited by 981
Exosomes in cancer development, metastasis, and immunity
Zhang, L., & Yu, D. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.004 · Cited by 870
Morrissey, S. M., Zhang, F., Ding, C., Montoya-Durango, D. E., Hu, X., Yang, C., Wang, Z., Yuan, F., Fox, M., Zhang, H.-G., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.002 · Cited by 605
Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris
Caruso, S., & Poon, I. K. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01486 · Cited by 541
Metadata
- Authors
- Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-07-22
- Volume
- 7
- Issue
- 35
- Pages
- 56279-56294
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2485668101
- Cited by
- 125
- References
- 10
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.